By Dr David Robert Croucher

Preprints

Horne CR; Dite TA; Young SN; Mather LJ; Dagley LF; Johnson JL; Yaron-Barir TM; Huntsman EM; Daly LA; Byrne DP; Cadell AL; Ng BH; Yousef J; Multari DH; Shen L; McAloon LM; Manning G; Febbraio MA; Means AR; Cantley LC; Tanzer MC; Croucher DR; Eyers CE; Eyers PA; Scott JW; Murphy JM, 2024, PSKH1 kinase activity is differentially modulated via allosteric binding of Ca²⁺sensor proteins, http://dx.doi.org/10.1101/2024.10.20.619163

Yang X; Ma X; Croucher DR; Nguyen EV; Clark KC; Hu C; Latham SL; Zhao T; Bayly-Jones C; Nguyen VCB; Shin S-Y; Nguyen LK; Cotton TR; Chüeh AC; Kam Sian TCCL; Stratton MM; Ellisdon AM; Daly RJ, 2024, Feed-forward stimulation of CAMK2 by the oncogenic pseudokinase PEAK1 generates a therapeutically 'actionable' signalling axis in triple negative breast cancer., http://dx.doi.org/10.1101/2024.02.14.580406

Walter S; Ho J; Alvarado R; Smith G; Croucher DR; Liang S; Es SLV; Earls P; Rimmer J; Campbell R; Kalish L; Sacks R; Harvey R, 2024, Mepolizumab decreases tissue eosinophils while increasing type-2 cytokines in eosinophilic chronic rhinosinusitis, http://dx.doi.org/10.22541/au.170669863.35814827/v1

Wahlroos S; Portman N; Bonder C; Hjorth M; Wilkinson A; Hastings J; Croucher D; Febbraio M; Gallego-Ortega D; Lim E, 2022, Exercise-induced modulation of the immune microenvironment in pre-clinical breast cancer models., http://dx.doi.org/10.21203/rs.3.rs-1789675/v1

Trevelyan SJ; Brewster JL; Burgess AE; Crowther JM; Cadell AL; Parker BL; Croucher DR; Dobson RCJ; Murphy JM; Mace PD, 2019, Mechanism of preferential complex formation by Apoptosis Signal-regulating Kinases, http://dx.doi.org/10.1101/693663

Hastings J; Gonzalez-Rajal A; Han JZR; McCloy R; O’Donnell YEI; Phimmachanh M; Murphy A; Nagrial A; Daneshvar D; Chin V; Watkins N; Burgess A; Croucher D, 2019, Dynamic analysis of pulsed cisplatin identifies effectors of resistance in lung adenocarcinoma, http://dx.doi.org/10.1101/775924

Back to profile page